Nanalysis Scientific Corp.
NSCI.V
TSX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -341.64% | 17.32% | 22.06% | 6.13% | 57.49% |
Total Depreciation and Amortization | -6.24% | 0.75% | -3.34% | 131.02% | -236.18% |
Total Amortization of Deferred Charges | -1.44% | 1.65% | 0.14% | -74.51% | -- |
Total Other Non-Cash Items | 740.31% | -10.01% | 14.98% | -10.01% | -77.26% |
Change in Net Operating Assets | 7.65% | -192.75% | -56.85% | 200.81% | -237.56% |
Cash from Operations | 421.88% | -130.71% | -29.00% | 157.91% | -85.75% |
Capital Expenditure | 100.00% | -528.57% | 98.07% | 55.51% | -1,713.33% |
Sale of Property, Plant, and Equipment | 321.86% | -28.52% | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | 100.00% |
Other Investing Activities | 19.81% | 14.92% | 6.88% | 51.29% | -15.70% |
Cash from Investing | 42.00% | 12.83% | 20.55% | 51.72% | 5.93% |
Total Debt Issued | 35.44% | -- | -- | -- | 33.19% |
Total Debt Repaid | 2.84% | -27.01% | 78.28% | -809.87% | 115.67% |
Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 11.90% | 15.44% | 15.82% | 63.95% | -271.97% |
Cash from Financing | 282.07% | 84.83% | -2,429.20% | -98.48% | 401.41% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 224.41% | -59.50% | -159.86% | 284.29% | 86.29% |